Juliá, Estefanía Paula
Mandó, Pablo
Rizzo, Manglio Miguel
Cueto, Gerardo Rubén
Tsou, Florencia
Luca, Romina
Pupareli, Carmen
Bravo, Alicia Inés
Astorino, Walter
Mordoh, José
Martín, Claudio
Levy, Estrella Mariel http://orcid.org/0000-0003-2954-6667
Funding for this research was provided by:
Consejo Nacional de Investigaciones Científicas y Técnicas
Fundación Sales
Fundación Cancer FUCA
Fundación P. Mosoteguy
Article History
Received: 2 April 2019
Accepted: 3 September 2019
First Online: 12 September 2019
Compliance with ethical standards
:
: Claudio Martín has served as speaker and advisory board member for Bristol Myers Squibb and Merck Sharp and Dohme. Carmen Pupareli has served as speaker and advisor board member for Merck Sharp and Dohme and as speaker for Bristol Myers Squibb. The authors declare that there is no other conflict of interest.
: All procedures involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Comité de Ética en Investigación del Instituto Alexander Fleming CEIAF, approval number: 616, 14th June 2016.
: All samples were taken after patients gave written informed consent approved by Comité de Ética en Investigación del Instituto Alexander Fleming CEIAF. Patients consented to the use of their specimens and data for research and for publication.